Home > Insider Trading > Filing (0001209191-13-029941)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
949699	Pharmacyclics Inc	PCYC	Pharmaceutical Preparations (2834)	943148201

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1507649	Gregory Hemmi	C/O Pharmacyclics, Inc. 995 East Arques Avenue Sunnyvale CA 94085	Vp Chemical Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-05-31	1,485	$0.86	25,721	No	4	M	Direct
Common Stock	Acquisiton	2013-05-31	48,515	$2.76	74,236	No	4	M	Direct
Cmmon Stock	Disposition	2013-05-31	50,000	$91.96	24,236	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Commn Stock	Stock Option (Right to Buy)	Disposition	2013-05-31	1,485	$0.00	1,485	$0.86
Common Stock	Stock Option (Right to Buy)	Disposition	2013-05-31	48,515	$0.00	48,515	$2.76

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
123,515	2008-03-18	2018-03-18	No	4	M	Direct
23,438	2007-03-13	2017-03-13	No	4	M	Direct

Footnotes

Option granted under the issuer's 2004 Equity Incentive Award Plan in a transaction exempt under rule 16b-3(d). The option vests as follows: 25% of the shares subject to the option will vest on March 18, 2009 and 1/36th of the remaining shares will vest monthly thereafter. Vesting related to period ending March 18, 2009 was subject to potential acceleration upon the attainment of certain corporate events.
Option granted under the issuer's 2004 Equity Incentive Award Plan in a transaction exempt under rule 16b-3(d). The option vests in forty-eight (48) equal and successive monthly installments.